Abstract
In the present work we have examined whether the neurosteroid pregnenolone has any neuroprotective effects against glutamate and amyloid beta protein neurotoxicity using immortalized clonal mouse hippocampal cell line (HT-22). The neurosteroid pregnenolone protects HT-22 cells against both 5 mM glutamate and 2 μM amyloid beta protein induced cell death in a concentration dependent manner. Optimum protection was attained at 500 nM pregnenolone, against both 5 mM glutamate as well as 2 μM amyloid beta protein induced HT-22 cell death. Furthermore, using confocal immunoflourescence microscopy we observed that 20 hours of treatment with 5 mM glutamate resulted in intense nuclear localization of the glucocorticoid receptor (GR) in HT-22 cells as compared to control untreated cells. Interestingly, 500 nM pregnenolone treatment for 24 hours, followed by 20 hours treatment with 5 mM glutamate resulted in dramatic reduction in GR nuclear localization. These results show that (i) pregnenolone has neuroprotective effects against both glutamate and amyloid beta protein neuropathology and (ii) prevention of glucocorticoid receptor (GR) localization to the nucleus may be involved in the observed neuroprotective effects of pregnenolone against glutamate neurotoxicity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Baulieu, E. 1998. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23:963–987.
Behl, C., Widman, M., Trapp, T., and Holsboer, F. 1995. 17β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:473–482.
Cardounel, A., Regelson, W., and Kalimi, M. 1999. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc. Soc. Expt. Biol. Med. 222:145–149.
Paul, S. and Purdy, R. 1992. Neurosteroids such as pregnenolone, dehydroepiandrosterone etc. are known to rapidly change the neuronal excitability by binding to membrane mediated excitatory and or inhibitory neurotransmitter receptors. FASEB J. 6:2311–2333.
Waters, S., Miller, G., Aleo, M.,and Schnellmann, R. 1997. Neurosteroid inhibition of cell death. Am. J. Physiol. 273:F869–F876.
Rupprecht, R. and Holsboer, F. 1999. Neuropsychopharmacological properties of neuroactive steroids. Steroids 64:83–91.
Rupprecht, R. Berning, B., Hauser, C., Holsboer, F., and Reul, J. 1996. Steroid receptor-mediated effects of neuroactive steroid: characterization of structure-activity relationship. Eur. J. Pharmacol. 15:227–234.
Baulieu, E. and Robel, P. 1990. Neurosteriods: a new brain function? J. Steroid Biochem. Mol. Biol. 37:395–403.
Tsutsui, K. and Ukena, K. 1999. Neurosteroids in the cerebellar purkinje neuron and their actions (review). Int. J. Mol. Med. 4:49–56.
Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C., and Holsboer, F. 1997. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharm. 51:535–541.
Goodman, Y., Bruce, A., Cheng, B., and Mattson, M. 1996. Estrogen attunes and corticosterone exacerbates excitoxicity oxidative injury and amyloid beta toxicity in hippocampal neurons. J. Neuro. Chem. 66:1836–1844.
Singer, C., Rogers, K., Strickland, T., and Dorsa, D. 1996. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212:13–16.
Rupprecht, R. and Holsboer, F. 1999. Neuroactive steroids: mechanism of action and neuropharmacological perspectives. Trends Neurosci. 22:410–416.
Weaver, C., Wu, F., Gibbs, T., and Farb, D. 1998. Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons. Brain Res. 803:129–136.
Behl, C., Lezoulac'h, F., Trapp, T., Widmann, M., Skutella, T., and Holsboer, F. 1997. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138:101–106.
McIntosh, L. and Sapolsky, R. 1996. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp. Neurol. 141:201–206.
Espey, M. and Basile, A. 1999. Glutamate augments retrovirusinduced immunodeficiency through chronic stimulation of the hypothalamic-pituitary-adrenal axis. J. Immuno. 162:4998–5002.
Feldman, S. and Weidenfeld, J. 1997. Hypothalamic mechanisms mediating glutamate effects on the hypothalamo-pituitaryadrenocortical axis. J. Neural Transm. 104:633–642.
Behl, C., Trapp, T., Skutella, T., and Holsboer, F. 1997. Protection against oxidative stress-induced neuronal cell death-a novel role for RU486. Eur. J. Neurosci. 9:912–920.
Corpecho, H., Singuelakis, S., Talha, M., Axelson, J., Sjovall, R., Vihko, E., Baulieu, E., and Robel, P. 1983 Pregnenolone and its sulfate ester in the rat brain. Brain Res. 270:119–125.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gursoy, E., Cardounel, A. & Kalimi, M. Pregnenolone Protects Mouse Hippocampal (HT-22) Cells against Glutamate and Amyloid Beta Protein Toxicity. Neurochem Res 26, 15–21 (2001). https://doi.org/10.1023/A:1007668213330
Issue Date:
DOI: https://doi.org/10.1023/A:1007668213330